# ALCAR Prophylaxis Study

> **NCT00225160** · PHASE2 · UNKNOWN · sponsor: **Royal Free Hampstead NHS Trust** · enrollment: 50 (—)

## Conditions studied

- HIV Infections
- Distal Symmetric Polyneuropathy

## Interventions

- **DRUG:** acetyl L-carnitine

## Key facts

- **NCT ID:** NCT00225160
- **Lead sponsor:** Royal Free Hampstead NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2008-09-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225160, "ALCAR Prophylaxis Study". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00225160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*